Curanex Pharmaceuticals Inc
Research Curanex Pharmaceuticals Inc (CURX) on Bullrun: market cap USD 7.55M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCURX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 7.55M
- Financial periodFY2025
- Net income-USD 4.23M
Valuation Snapshot
latest market cap is USD 7.55M.
About Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023.
Frequently asked questions
What is Curanex Pharmaceuticals Inc's market cap?
Curanex Pharmaceuticals Inc's market capitalization is USD 7.55M.
What does Curanex Pharmaceuticals Inc do?
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases.